rs121909650
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_182925.5(FLT4):c.3122G>C(p.Arg1041Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1041Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_182925.5 missense
Scores
Clinical Significance
Conservation
Publications
- lymphatic malformation 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- capillary infantile hemangiomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- congenital heart defects, multiple types, 7Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- lymphatic malformationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- tetralogy of fallotInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
FLT4-related disorder Pathogenic:1
The FLT4 c.3122G>C variant is predicted to result in the amino acid substitution p.Arg1041Pro. This variant has been reported in individuals with primary lymphoedema in a segregation study and the functional study showed that this variant results in encoded protein with an inactive tyrosine kinase and preventing downstream gene activation (Karkkainen et al. 2000. PubMed ID: 10835628). Additionally, different missense substitutions at this same codon (p.Arg1041Trp and p.Arg1041Gln) have been reported in individuals with primary lymphoedema (Evans et al. 2003. PubMed ID: 12960217; Liu et al. 2021. PubMed ID: 34681005) suggesting that substitution of amino acid residue p.Arg1041 is not tolerated. This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as pathogenic. -
not provided Pathogenic:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 10835628, 11114740, 17250670, 19002718, 12960217, 23074044) -
Hereditary lymphedema type I Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at